> top > docs > PMC:7755033 > spans > 83207-84014 > annotations

PMC:7755033 / 83207-84014 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
1472 104-106 Species denotes WS Tax:126910
1473 272-274 Species denotes WS Tax:126910
1474 549-551 Species denotes WS Tax:126910
1475 191-209 Chemical denotes hydroxychloroquine MESH:D006886
1476 214-224 Chemical denotes poziotinib MESH:C557213
1477 373-383 Chemical denotes cinacalcet MESH:D000069449
1478 388-398 Chemical denotes oberadilol
1479 454-464 Chemical denotes poziotinib MESH:C557213
1480 661-673 Chemical denotes procainamide MESH:D011342
1481 730-740 Chemical denotes poziotinib MESH:C557213

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T845 0-53 Sentence denotes The obtained results have been presented in Table 15.
T846 54-259 Sentence denotes As is evident from Table 15, none of the analyzed WS phytoconstituents had any mutagenic effects in contrast to standard reference drugs hydroxychloroquine and poziotinib which displayed high mutagenicity.
T847 260-503 Sentence denotes Most of the WS phytoconstituents displayed little to no tumorigenicity in comparison to standard reference drugs cinacalcet and oberadilol which exhibited a high tendency for tumorigenicity and poziotinib which exhibited a mild tumorigenicity.
T848 504-807 Sentence denotes The irritant and reproductive effects of the WS phytoconstituents were also predicted to be from negligible to none, in contrast to standard reference drugs procainamide which was predicted to possess high adverse effects and poziotinib that was predicted to have mild irritant and reproductive effects.